Xtl Biopharmaceuticals Ltd (XTLB) Return on Investment ROI from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, average high and low, overall ranking from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Xtl Biopharmaceuticals Ltd   (NASDAQ: XTLB)


Xtl Biopharmaceuticals Ltd's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Xtl Biopharmaceuticals Ltd's ROI in the fourth quarter of 2023?


Within the Healthcare sector 352 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2023 from 0 to 4091.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Investment Change TTM -17.8 % -55.59 % -49.43 % -47.18 % -45.44 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 5 0 2 2 2
Return On Investment (TTM) 0 % 0 % 0 % -10.7 % -9.17 %
XTLB's Overall Ranking # 4091 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 45.87 % -21.07 % -16.69 % -14.3 % -21.18 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 0 0 0 0 0

XTLB Company Profile >> Back to XTLB Roi Comparisons >> See Annual XTLB Return On Investment



Return On Investment XTLB's Ranking
Within: No.
Industry # 128
Sector # 353
Overall # 4091

Return On Investment Statistics
High Average Low
48.23 %
-14.25 %
-76.41 %
(Dec 31 2018)   (Dec 31 2020)







Financial Statements
Xtl Biopharmaceuticals Ltd's IV. Quarter Investments $ 5 Millions XTLB's Balance sheet
Xtl Biopharmaceuticals Ltd's IV. Quarter Income $ 0 Millions Quarterly XTLB's Income Statement
XTLB's Income by Division See XTLB's Income by Division


XTLB Annual Return On Investment (Dec 31 2023)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 5 2 4 7 4
Y / Y Investment Growth 144.82 % -44.49 % -39.57 % 71.18 % -42.7 %
Net Income in Millions -1 -2 -1 0 -3
Y / Y Net Income Growth - - - - -
Annual Return On Investment -18.9 % -80.27 % -33.71 % 6.57 % -76.41 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
XTLB's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for XTLB's Competitors
Subscribers only: Roi for Xtl Biopharmaceuticals Ltd's Suppliers
Subscribers only: Return On Investment for XTLB's Customers

Other Ratios
XTLB's Roa XTLB's Inventory Turnover Ratio XTLB's Growth Rates XTLB's Dividend Statistics
XTLB's Profitability Ratios XTLB's Asset Turnover Ratio XTLB's Dividend Growth
XTLB's Roe XTLB's Valuation Ratios XTLB's Financial Strength Ratios XTLB's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI

Date modified: 2024-05-02T15:34:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.